Course: Expert Exchanges on the Evolving Treatment Landscape of Acute Lymphoblastic Leukemia
CME Credits: 1.00
Released: 2026-10-14
This expert-exchange activity is designed for hematologists/oncologists in academic and community settings and their multidisciplinary teams who manage pediatric and adult patients with acute lymphoblastic leukemia (ALL). Through candid faculty dialogue, the program examines recent clinical advances in induction/consolidation regimens, targeted therapies, and immunotherapies, along with the expanding role of MRD-guided decision-making across the disease continuum. Participants will explore how to translate the latest evidence into personalized, risk-adapted treatment plans for patients with Philadelphia chromosome–positive (Ph+) and Ph-negative (Ph?) B-ALL, and how to implement effective monitoring and management strategies for treatment-related adverse events. By addressing persistent gaps in therapy selection and sequencing, this activity aims to improve remission durability, reduce avoidable toxicity, and optimize long-term outcomes in real-world practice. This activity is derived from a Live ISS at SOHO, originally held on September 10, 2026.
After completing this activity, the participant should be better able to:
View Full Course